ARTV insider filings

Artiva Biotherapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen ARTV transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 40 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Aslan Fred — Chief Executive Officer, Director8—6 legs · 352,425 sh · $2,265,3504
Horan Christopher — Chief Tech Operations Officer5—4 legs · 51,675 sh · $310,2882
Bush Jennifer — COO, CLO, Compliance Officer5—4 legs · 44,417 sh · $261,2922
Banerjee Subhashis — Chief Medical Officer6—5 legs · 15,568 sh · $138,9544
Miralles Gines Diego — President & Head of R&D2—1 leg · 1,043 sh · $4,0802
Baker Daniel G. — Director2——2
DANIELS BRIAN — Director2——2
HOUGEN ELIZABETH L — Director2——2
MOORE ALISON — Director2——2
RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner & RA Capital Healthcare Fund LP — Director, 10% owner & RA Capital Nexus Fund, L.P. — Director & RA Capital Nexus Fund III, L.P. — Director & Kolchinsky Peter — Director, 10% owner & Shah Rajeev M. — Director, 10% owner2——2

+2 more insiders in the window, not shown — every filing appears in the table below.

Recent insider filings — Artiva Biotherapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-184Aslan Fred — Chief Executive Officer, DirectorSale (S): 119,771 @ $3.91EDGAR
2026-11-184Banerjee Subhashis — Chief Medical OfficerSale (S): 4,037 @ $3.91EDGAR
2026-11-184Bush Jennifer — COO, CLO, Compliance OfficerSale (S): 19,217 @ $3.91EDGAR
2026-11-184Horan Christopher — Chief Tech Operations OfficerSale (S): 20,546 @ $3.91EDGAR
2026-11-184Miralles Gines Diego — President & Head of R&DSale (S): 1,043 @ $3.91EDGAR
2026-11-034Bush Jennifer — COO, CLO, Compliance OfficerSale (S): 8,439 @ $4.18EDGAR
2026-11-034Horan Christopher — Chief Tech Operations OfficerSale (S): 10,423 @ $4.18EDGAR
2026-11-034Aslan Fred — Chief Executive Officer, DirectorSale (S): 62,178 @ $4.18EDGAR
2026-11-034Banerjee Subhashis — Chief Medical OfficerSale (S): 1,110 @ $4.18EDGAR
2026-10-074Aslan Fred — Chief Executive Officer, DirectorSale (S): 23,463 @ $7.20EDGAR
2026-10-064Aslan Fred — Chief Executive Officer, DirectorSale (S): 61,696 @ $6.84EDGAR
2026-10-064Banerjee Subhashis — Chief Medical OfficerSale (S): 1,099 @ $6.84EDGAR
2026-10-064Bush Jennifer — COO, CLO, Compliance OfficerSale (S): 8,370 @ $6.84EDGAR
2026-10-064Horan Christopher — Chief Tech Operations OfficerSale (S): 10,340 @ $6.84EDGAR
2026-09-154Aslan Fred — Chief Executive Officer, DirectorGrant/award (A): 110,000 @ $0 · Grant/award (A): 315,000 (derivative) @ $0EDGAR
2026-09-144Aslan Fred — Chief Executive Officer, DirectorGrant/award (A): 45,000 @ $0 · Grant/award (A): 155,000 (derivative) @ $0EDGAR
2026-09-144RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Grant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-144MOORE ALISON — DirectorGrant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-144Baker Daniel G. — DirectorGrant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-144DANIELS BRIAN — DirectorGrant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-144HOUGEN ELIZABETH L — DirectorGrant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-144Sorg Elaine K. — DirectorGrant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-144Stoppel Laura — DirectorGrant/award (A): 16,250 (derivative) @ $0EDGAR
2026-09-114Miralles Gines Diego — President & Head of R&DGrant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2026-09-114Banerjee Subhashis — Chief Medical OfficerGrant/award (A): 30,000 @ $0 · Grant/award (A): 85,000 (derivative) @ $0EDGAR
2026-09-114Bush Jennifer — COO, CLO, Compliance OfficerGrant/award (A): 45,000 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2026-09-114Horan Christopher — Chief Tech Operations OfficerGrant/award (A): 40,000 @ $0 · Grant/award (A): 120,000 (derivative) @ $0EDGAR
2026-09-094Aslan Fred — Chief Executive Officer, DirectorSale (S): 23,429 @ $10.92EDGAR
2026-09-084RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Grant/award (A): 13,750 (derivative) @ $0EDGAR
2026-09-084Stoppel Laura — DirectorGrant/award (A): 13,750 (derivative) @ $0EDGAR
2026-09-084Baker Daniel G. — DirectorGrant/award (A): 13,750 (derivative) @ $0EDGAR
2026-09-084DANIELS BRIAN — DirectorGrant/award (A): 13,750 (derivative) @ $0EDGAR
2026-09-084HOUGEN ELIZABETH L — DirectorGrant/award (A): 13,750 (derivative) @ $0EDGAR
2026-09-084Sorg Elaine K. — DirectorGrant/award (A): 13,750 (derivative) @ $0EDGAR
2026-09-084MOORE ALISON — DirectorGrant/award (A): 13,750 (derivative) @ $0EDGAR
2026-09-044Aslan Fred — Chief Executive Officer, DirectorSale (S): 61,888 @ $11.16EDGAR
2026-09-044Banerjee Subhashis — Chief Medical OfficerSale (S): 1,100 @ $11.16EDGAR
2026-09-044Bush Jennifer — COO, CLO, Compliance OfficerSale (S): 8,391 @ $11.16EDGAR
2026-09-044Horan Christopher — Chief Tech Operations OfficerSale (S): 10,366 @ $11.16EDGAR
2026-08-314Banerjee Subhashis — Chief Medical OfficerOption exercise (M): 5,306 @ $1.92 · Sale (S): 8,222 @ $12.01 · Option exercise (M): 5,306 (derivative) @ $0EDGAR
2026-08-194Banerjee Subhashis — Chief Medical OfficerOption exercise (M): 429 @ $1.92 · Sale (S): 429 @ $12 · Option exercise (M): 429 (derivative) @ $0EDGAR
2026-07-314RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 20,824 @ $9.99 · Purchase (P): 24,944 @ $9.93EDGAR
2026-07-284RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 41,319 @ $9.99EDGAR
2026-07-234RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 120,582 @ $9.55 · Purchase (P): 84,124 @ $9.93 · Purchase (P): 59,880 @ $9.96EDGAR
2026-07-234/ARA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 6,522 @ $8.94EDGAR
2026-07-204RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 152,472 @ $8.93 · Purchase (P): 7,882 @ $8.95EDGAR
2026-07-144RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 15,102 @ $8.97 · Purchase (P): 6,552 @ $8.94EDGAR
2026-06-294RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 31,000 @ $8.88 · Purchase (P): 1,876 @ $8.98EDGAR
2026-06-164RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 391,019 @ $8.57 · Purchase (P): 15,414 @ $8.99 · Purchase (P): 124,893 @ $8.89EDGAR
2026-06-114RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Purchase (P): 479,039 @ $6.91 · Purchase (P): 103 @ $7 · Purchase (P): 548,580 @ $7.91EDGAR

Recent 8-K events — Artiva Biotherapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-11-098-K/A?EDGAR
2026-10-278-K2.02 — Results of Operations and Financial Condition
?
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-228-K8.01 — Other EventsEDGAR
2026-05-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-05-088-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ARTV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs